• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过多组学解析毛蕊异黄酮在肺腺癌中的抗癌机制:靶向肿瘤微环境中SMAD3介导的NOTCH信号通路

Deciphering Anticancer Mechanisms of Calycosin in Lung Adenocarcinoma Through Multi-Omics: Targeting SMAD3-Mediated NOTCH Signaling in the Tumor Microenvironment.

作者信息

Zhang Bi-Tian, Song Xiaoyu, Cho Chi-Shing William, Wong Chun-Kwok, Wang Dongjie

机构信息

Institute of Chinese Medicine and State Key Laboratory of Research on Bioactivities and Clinical Applications of Medicinal Plants, The Chinese University of Hong Kong, Hong Kong, China.

School of Life Science and Technology, Harbin Institute of Technology, Harbin 150001, China.

出版信息

Cancers (Basel). 2025 Apr 26;17(9):1455. doi: 10.3390/cancers17091455.

DOI:10.3390/cancers17091455
PMID:40361382
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12071042/
Abstract

OBJECTIVE

Lung adenocarcinoma (LUAD) remains a leading cause of cancer-related mortality, particularly in advanced stages. This study investigates the anticancer mechanisms of calycosin, an isoflavonoid derived from , in LUAD.

METHODS

Using integrative approaches including bulk and single-cell RNA sequencing, network pharmacology, and molecular docking, we identified SMAD3 as a critical biomarker associated with LUAD staging and prognosis.

RESULTS

Calycosin targets SMAD3, modulating the NOTCH signaling pathway in monocytes/macrophages to suppress tumor growth, invasion, and immune evasion. Enrichment analyses revealed significant involvement of NOTCH signaling components in SMAD3-correlated genes, particularly in advanced-stage LUAD. Single-cell RNA sequencing further demonstrated NOTCH pathway enrichment in tumor-associated monocytes/macrophages. Additionally, KMT2A was identified as a key transcriptional regulator in these cells.

CONCLUSIONS

These findings highlight the potential effects of calycosin and provide novel insights into targeting the tumor-immune microenvironment in LUAD.

摘要

目的

肺腺癌(LUAD)仍然是癌症相关死亡的主要原因,尤其是在晚期。本研究调查了毛蕊异黄酮(一种从[来源未提及]衍生的异黄酮)在LUAD中的抗癌机制。

方法

我们采用包括批量和单细胞RNA测序、网络药理学和分子对接在内的综合方法,确定SMAD3是与LUAD分期和预后相关的关键生物标志物。

结果

毛蕊异黄酮靶向SMAD3,调节单核细胞/巨噬细胞中的NOTCH信号通路,以抑制肿瘤生长、侵袭和免疫逃逸。富集分析显示NOTCH信号成分在与SMAD3相关的基因中显著参与,特别是在晚期LUAD中。单细胞RNA测序进一步证明了肿瘤相关单核细胞/巨噬细胞中NOTCH通路的富集。此外,KMT2A被确定为这些细胞中的关键转录调节因子。

结论

这些发现突出了毛蕊异黄酮的潜在作用,并为靶向LUAD中的肿瘤免疫微环境提供了新的见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ba0/12071042/b780cead3edc/cancers-17-01455-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ba0/12071042/cbb6b91c43bf/cancers-17-01455-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ba0/12071042/e9d24aa64178/cancers-17-01455-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ba0/12071042/e490cf15193f/cancers-17-01455-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ba0/12071042/d26d3ebaa8fc/cancers-17-01455-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ba0/12071042/654f984ccced/cancers-17-01455-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ba0/12071042/d0083fc8e713/cancers-17-01455-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ba0/12071042/b780cead3edc/cancers-17-01455-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ba0/12071042/cbb6b91c43bf/cancers-17-01455-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ba0/12071042/e9d24aa64178/cancers-17-01455-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ba0/12071042/e490cf15193f/cancers-17-01455-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ba0/12071042/d26d3ebaa8fc/cancers-17-01455-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ba0/12071042/654f984ccced/cancers-17-01455-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ba0/12071042/d0083fc8e713/cancers-17-01455-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ba0/12071042/b780cead3edc/cancers-17-01455-g007.jpg

相似文献

1
Deciphering Anticancer Mechanisms of Calycosin in Lung Adenocarcinoma Through Multi-Omics: Targeting SMAD3-Mediated NOTCH Signaling in the Tumor Microenvironment.通过多组学解析毛蕊异黄酮在肺腺癌中的抗癌机制:靶向肿瘤微环境中SMAD3介导的NOTCH信号通路
Cancers (Basel). 2025 Apr 26;17(9):1455. doi: 10.3390/cancers17091455.
2
Integrated analysis of single-cell RNA-seq and bulk RNA-seq reveals immune suppression subtypes and establishes a novel signature for determining the prognosis in lung adenocarcinoma.单细胞 RNA-seq 和批量 RNA-seq 的综合分析揭示了免疫抑制亚型,并建立了一个新的特征,用于确定肺腺癌的预后。
Cell Oncol (Dordr). 2024 Oct;47(5):1697-1713. doi: 10.1007/s13402-024-00948-4. Epub 2024 Apr 15.
3
Multi-omics immune regulatory mechanisms in lung adenocarcinoma metastasis and survival time.肺腺癌转移和生存时间的多组学免疫调控机制。
Comput Biol Med. 2023 Sep;164:107333. doi: 10.1016/j.compbiomed.2023.107333. Epub 2023 Aug 12.
4
Single-cell RNA sequencing reveals immune microenvironment niche transitions during the invasive and metastatic processes of ground-glass nodules and part-solid nodules in lung adenocarcinoma.单细胞 RNA 测序揭示肺腺癌磨玻璃结节和部分实性结节侵袭转移过程中免疫微环境龛的转变。
Mol Cancer. 2024 Nov 23;23(1):263. doi: 10.1186/s12943-024-02177-7.
5
An integrated bioinformatic analysis of bulk and single-cell sequencing clarifies immune microenvironment and metabolic profiles of lung adenocarcinoma to predict immunotherapy efficacy.对 bulk 和单细胞测序的综合生物信息学分析阐明了肺腺癌的免疫微环境和代谢特征,以预测免疫治疗疗效。
Front Cell Dev Biol. 2023 Apr 5;11:1163314. doi: 10.3389/fcell.2023.1163314. eCollection 2023.
6
Super-enhancer hijacking LINC01977 promotes malignancy of early-stage lung adenocarcinoma addicted to the canonical TGF-β/SMAD3 pathway.超级增强子劫持 LINC01977 促进依赖经典 TGF-β/SMAD3 通路的早期肺腺癌恶性转化。
J Hematol Oncol. 2022 Aug 18;15(1):114. doi: 10.1186/s13045-022-01331-2.
7
Integrative multi-omics analysis for identifying novel therapeutic targets and predicting immunotherapy efficacy in lung adenocarcinoma.整合多组学分析用于鉴定肺腺癌中的新型治疗靶点及预测免疫治疗疗效
Cancer Drug Resist. 2025 Jan 14;8:3. doi: 10.20517/cdr.2024.91. eCollection 2025.
8
Single-cell and bulk RNA-sequencing reveal SPP1 and CXCL12 as cell-to-cell communication markers to predict prognosis in lung adenocarcinoma.单细胞和批量 RNA 测序揭示 SPP1 和 CXCL12 作为细胞间通讯标志物,可预测肺腺癌的预后。
Environ Toxicol. 2024 Oct;39(10):4610-4622. doi: 10.1002/tox.24297. Epub 2024 Apr 15.
9
Integrating bulk-RNA sequencing and single-cell sequencing analyses to characterize adenosine-enriched tumor microenvironment landscape and develop an adenosine-related prognostic signature predicting immunotherapy in lung adenocarcinoma.整合 bulk-RNA 测序和单细胞测序分析,以描绘富含腺苷的肿瘤微环境景观,并开发一个与腺苷相关的预后标志物,用于预测肺腺癌的免疫治疗反应。
Funct Integr Genomics. 2024 Jan 24;24(1):19. doi: 10.1007/s10142-023-01281-z.
10
Calycosin Inhibits the Malignant Behaviors of Lung Adenocarcinoma Cells by Regulating the circ_0001946/miR-21/GPD1L/HIF-1 Signaling Axis.毛蕊异黄酮通过调控 circ_0001946/miR-21/GPD1L/HIF-1 信号轴抑制肺腺癌细胞的恶性行为。
Dis Markers. 2022 Aug 13;2022:3969389. doi: 10.1155/2022/3969389. eCollection 2022.

本文引用的文献

1
Notch signaling in cancers: mechanism and potential therapy.癌症中的Notch信号传导:机制与潜在疗法。
Front Cell Dev Biol. 2025 Feb 20;13:1542967. doi: 10.3389/fcell.2025.1542967. eCollection 2025.
2
Targeting PI3K signaling in Lung Cancer: advances, challenges and therapeutic opportunities.肺癌中PI3K信号通路的靶向治疗:进展、挑战与治疗机遇
J Transl Med. 2025 Feb 14;23(1):184. doi: 10.1186/s12967-025-06144-8.
3
Highly proliferating cancer cells function as novel prognostic biomarkers for lung adenocarcinoma with particular usefulness for stage IA risk stratification.
高度增殖的癌细胞可作为肺腺癌新的预后生物标志物,对IA期风险分层尤为有用。
BMC Cancer. 2025 Jan 7;25(1):25. doi: 10.1186/s12885-024-13308-0.
4
The Immunomodulatory Effects of Vitamin D on COVID-19 Induced Glioblastoma Recurrence via the PI3K-AKT Signaling Pathway.维生素D通过PI3K-AKT信号通路对新冠病毒诱导的胶质母细胞瘤复发的免疫调节作用
Int J Mol Sci. 2024 Dec 2;25(23):12952. doi: 10.3390/ijms252312952.
5
Analysis of PD1, LAG3, TIGIT, and TIM3 expression in human lung adenocarcinoma reveals a 25-gene signature predicting immunotherapy response.对人肺腺癌中PD1、LAG3、TIGIT和TIM3表达的分析揭示了一种预测免疫治疗反应的25基因特征。
Cell Rep Med. 2024 Dec 17;5(12):101831. doi: 10.1016/j.xcrm.2024.101831. Epub 2024 Nov 25.
6
: A Traditional Chinese Medicine with Multifaceted Impacts on Breast Cancer Treatment.一种对乳腺癌治疗具有多方面影响的中药。
Biomolecules. 2024 Oct 21;14(10):1339. doi: 10.3390/biom14101339.
7
Dissecting transcriptome signals of anti-PD-1 response in lung adenocarcinoma.解析肺腺癌抗 PD-1 反应的转录组信号。
Sci Rep. 2024 Sep 10;14(1):21096. doi: 10.1038/s41598-024-72108-5.
8
Notch signaling pathway in cancer: from mechanistic insights to targeted therapies. Notch 信号通路与癌症:从机制研究到靶向治疗。
Signal Transduct Target Ther. 2024 May 27;9(1):128. doi: 10.1038/s41392-024-01828-x.
9
Dark under the Lamp: Neglected Biological Pollutants in the Environment Are Closely Linked to Lung Cancer.灯下黑:环境中被忽视的生物污染物与肺癌密切相关。
Int J Mol Sci. 2024 Mar 7;25(6):3081. doi: 10.3390/ijms25063081.
10
The tumor microenvironment: shaping cancer progression and treatment response.肿瘤微环境:塑造癌症进展与治疗反应
J Chemother. 2025 Feb;37(1):15-44. doi: 10.1080/1120009X.2023.2300224. Epub 2024 Jan 5.